Drug Shortage Report for JAMP DESVENLAFAXINE
Report ID | 192208 |
Drug Identification Number | 02495147 |
Brand name | JAMP DESVENLAFAXINE |
Common or Proper name | Desvenlafaxine Extended Release Tablets |
Company Name | JAMP PHARMA CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | DESVENLAFAXINE |
Strength(s) | 100MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL |
Packaging size | 90 |
ATC code | N06AX |
ATC description | ANTIDEPRESSANTS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2023-05-10 |
Estimated end date | 2024-05-31 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-03-12 |
Company comments | Increase in demand. Under allocation. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v14 | 2024-03-12 | French | Compare |
v13 | 2024-03-12 | English | Compare |
v12 | 2023-11-28 | French | Compare |
v11 | 2023-11-28 | English | Compare |
v10 | 2023-09-26 | French | Compare |
v9 | 2023-09-26 | English | Compare |
v8 | 2023-09-11 | French | Compare |
v7 | 2023-09-11 | English | Compare |
v6 | 2023-08-25 | French | Compare |
v5 | 2023-08-25 | English | Compare |
v4 | 2023-08-08 | French | Compare |
v3 | 2023-08-08 | English | Compare |
v2 | 2023-05-11 | French | Compare |
v1 | 2023-05-11 | English | Compare |
Showing 1 to 14 of 14